Science and Media Culture Clash

I read your editorial with interest,1 since most of my career as a journalist has been spent writing about scientific and technical topics. A few observations:1. Most scientists are elitist. They seem to feel that no one bereft of a PhD in their fields can possibly understand what they will say, so therefore they feel no obligation to simplify their presentations.2. Reporters want the who, what, where, when, why, and how. Note the order here. The why and how, which are the meat of the story for

Written byFrancis Hamit
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I read your editorial with interest,1 since most of my career as a journalist has been spent writing about scientific and technical topics. A few observations:

1. Most scientists are elitist. They seem to feel that no one bereft of a PhD in their fields can possibly understand what they will say, so therefore they feel no obligation to simplify their presentations.

2. Reporters want the who, what, where, when, why, and how. Note the order here. The why and how, which are the meat of the story for a scientist, are last. The reporters want the other answers first, and then, if there is room, they will get to the complicated stuff. By "room," I mean the assigned story length; reporters could be forced to make a long story short.

Many of the complaints about reporters getting the story wrong revolve around how the story was told in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies